Cyagen US Inc., headquartered in the United States, is a leading player in the biotechnology industry, specialising in custom gene editing, transgenic models, and advanced cell line development. Founded in 2005, the company has established a strong presence in major operational regions, including North America and Asia, and has achieved significant milestones in the field of genetic engineering. Cyagen's core offerings include CRISPR gene editing services, custom mouse models, and a range of cell line development solutions, all designed to accelerate research and innovation in life sciences. What sets Cyagen apart is its commitment to quality and customer-centric solutions, ensuring that researchers have access to cutting-edge technologies tailored to their specific needs. With a robust market position and a reputation for excellence, Cyagen US Inc. continues to drive advancements in biotechnology, supporting scientific breakthroughs worldwide.
How does Cyagen US Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cyagen US Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cyagen US Inc. currently does not report any carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any specific reduction targets or initiatives related to climate commitments. Without emissions data or defined climate strategies, it is unclear how Cyagen US Inc. is addressing its environmental impact. The absence of reported figures suggests a need for further transparency in their climate-related efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cyagen US Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
